Navigation Links
Milk Thistle Not An Effective Cure For Liver Disease

The health benefits of milk thistle, an herbal remedy employed in the treatment of liver disease has been questioned with a recent study highlighting the lack of evidence for its safety and efficacy // . There has been a good market for thistle milk, with over 1 million people suffering from liver disease (Hepatitis B, Hepatitis C or alcoholic liver disease) worldwide.

The research team analyzed the results of 13 different clinical trials involving the use of milk thistle in patients with liver disease due to alcoholism or hepatitis B or C. According to the predefined criteria, data pertaining to 6 different placebo-controlled, double blind studies were taken into consideration.

Following analysis, no beneficial effects of thistle milk could be found with respect to rate of mortality or complications associated with liver disease. Infact, it was nothing more than a placebo.

When the adverse effect factor was analyzed, no significant increase in the adverse effect was evident. However, this alone cannot mean that milk thistle is a harmless remedy for liver disease.

As there is an increased tendency of people to switch over to alternative treatment forms in place of conventional medicine, the more is the necessity of data to support the claimed health benefits. Sellers of such herbal products should also take this into consideration.

"We can't see beneficial effects, we can't exclude harmful effects, and in order to know more we need to do more randomized trials to find out do they actually help. My advice to people is don't use them before you have seen valid, trustworthy, low bias clinical trials that these drugs may actually benefit you more than they may harm you," said Dr. Christian Gluud, the lead author of the study from Copenhagen University Hospital.

Reports of high heavy metal content in ayurvedic medicines, the associated risk of heavy metal poisoning and the lack of clinical
'"/>




Page: 1 2

Related medicine news :

1. A Wonder Drug From Milk Thistle
2. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
3. Inhaled Steroids Safe & Effective for Children with Asthma
4. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
5. Fluoride Found Effective in Osteoporosis
6. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
7. Implantable Contact Lens Found Safe and Effective
8. Effective And Economical Agent For Anthrax
9. Stem Cell Transplants May Be Effective For MS Patients
10. Effective therapy for Huntingtons disease
11. Chemotherapy Effective for Bladder Cancer
Post Your Comments:
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 1TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7